Optimal Catheter Ablation Strategy for Patients with Persistent Atrial Fibrillation and Heart Failure: A Retrospective Study
The optimal catheter ablation (CA) strategy for patients with persistent atrial fibrillation (PeAF) and heart failure (HF) remains uncertain. Between 2016 and 2020, 118 consecutive patients with PeAF and HF who underwent the CA procedure in two centers were retrospectively evaluated and divided into...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2022-01-01
|
| Series: | Cardiology Research and Practice |
| Online Access: | http://dx.doi.org/10.1155/2022/3002391 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849305311578423296 |
|---|---|
| author | Cheng-ming Ma Ye-jian He Wen-wen Li Hua-min Tang Shi-yu Dai Xiao-meng Yin Xian-jie Xiao Yun-long Xia Lian-jun Gao Yuan-jun Sun Zhong-zhen Wang Rong-feng Zhang |
| author_facet | Cheng-ming Ma Ye-jian He Wen-wen Li Hua-min Tang Shi-yu Dai Xiao-meng Yin Xian-jie Xiao Yun-long Xia Lian-jun Gao Yuan-jun Sun Zhong-zhen Wang Rong-feng Zhang |
| author_sort | Cheng-ming Ma |
| collection | DOAJ |
| description | The optimal catheter ablation (CA) strategy for patients with persistent atrial fibrillation (PeAF) and heart failure (HF) remains uncertain. Between 2016 and 2020, 118 consecutive patients with PeAF and HF who underwent the CA procedure in two centers were retrospectively evaluated and divided into the pulmonary vein isolation (PVI)-only and PVI + additional ablation groups. Transthoracic echocardiography (TTE) was performed at baseline, one month, and 12 months after the CA procedure. The HF symptoms and left ventricular ejection fraction (LVEF) improvements were analyzed. Fifty-six patients underwent PVI only, and 62 patients received PVI with additional ablation. Compared with the baseline, a significant improvement in the LVEF and left atrial diameter postablation was observed in all patients. No significant HF improvement was detected in the PVI + additional ablation group than in the PVI-only group (74.2% vs. 71.4%, P=0.736), but the procedure and ablation time were significantly longer (137.4 ± 7.5 vs. 123.1 ± 11.5 min, P=0.001). There was no significant difference in the change in TTE parameters and the number of rehospitalizations. For patients with PeAF and HF, CA appears to improve left ventricular function. Additional ablation does not improve outcomes and has a significantly longer procedure time. Trial registration number is as follows: ChiCTR2100053745 (Chinese Clinical Trial Registry; https://www.chictr.org.cn/index.aspx). |
| format | Article |
| id | doaj-art-090c050f4b1f4607a36d41d7ea9b1fa2 |
| institution | Kabale University |
| issn | 2090-0597 |
| language | English |
| publishDate | 2022-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Cardiology Research and Practice |
| spelling | doaj-art-090c050f4b1f4607a36d41d7ea9b1fa22025-08-20T03:55:29ZengWileyCardiology Research and Practice2090-05972022-01-01202210.1155/2022/3002391Optimal Catheter Ablation Strategy for Patients with Persistent Atrial Fibrillation and Heart Failure: A Retrospective StudyCheng-ming Ma0Ye-jian He1Wen-wen Li2Hua-min Tang3Shi-yu Dai4Xiao-meng Yin5Xian-jie Xiao6Yun-long Xia7Lian-jun Gao8Yuan-jun Sun9Zhong-zhen Wang10Rong-feng Zhang11Department of CardiologyDepartment of CardiologyDepartment of Critically Care MedicineDepartment of Graduate SchoolDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyThe optimal catheter ablation (CA) strategy for patients with persistent atrial fibrillation (PeAF) and heart failure (HF) remains uncertain. Between 2016 and 2020, 118 consecutive patients with PeAF and HF who underwent the CA procedure in two centers were retrospectively evaluated and divided into the pulmonary vein isolation (PVI)-only and PVI + additional ablation groups. Transthoracic echocardiography (TTE) was performed at baseline, one month, and 12 months after the CA procedure. The HF symptoms and left ventricular ejection fraction (LVEF) improvements were analyzed. Fifty-six patients underwent PVI only, and 62 patients received PVI with additional ablation. Compared with the baseline, a significant improvement in the LVEF and left atrial diameter postablation was observed in all patients. No significant HF improvement was detected in the PVI + additional ablation group than in the PVI-only group (74.2% vs. 71.4%, P=0.736), but the procedure and ablation time were significantly longer (137.4 ± 7.5 vs. 123.1 ± 11.5 min, P=0.001). There was no significant difference in the change in TTE parameters and the number of rehospitalizations. For patients with PeAF and HF, CA appears to improve left ventricular function. Additional ablation does not improve outcomes and has a significantly longer procedure time. Trial registration number is as follows: ChiCTR2100053745 (Chinese Clinical Trial Registry; https://www.chictr.org.cn/index.aspx).http://dx.doi.org/10.1155/2022/3002391 |
| spellingShingle | Cheng-ming Ma Ye-jian He Wen-wen Li Hua-min Tang Shi-yu Dai Xiao-meng Yin Xian-jie Xiao Yun-long Xia Lian-jun Gao Yuan-jun Sun Zhong-zhen Wang Rong-feng Zhang Optimal Catheter Ablation Strategy for Patients with Persistent Atrial Fibrillation and Heart Failure: A Retrospective Study Cardiology Research and Practice |
| title | Optimal Catheter Ablation Strategy for Patients with Persistent Atrial Fibrillation and Heart Failure: A Retrospective Study |
| title_full | Optimal Catheter Ablation Strategy for Patients with Persistent Atrial Fibrillation and Heart Failure: A Retrospective Study |
| title_fullStr | Optimal Catheter Ablation Strategy for Patients with Persistent Atrial Fibrillation and Heart Failure: A Retrospective Study |
| title_full_unstemmed | Optimal Catheter Ablation Strategy for Patients with Persistent Atrial Fibrillation and Heart Failure: A Retrospective Study |
| title_short | Optimal Catheter Ablation Strategy for Patients with Persistent Atrial Fibrillation and Heart Failure: A Retrospective Study |
| title_sort | optimal catheter ablation strategy for patients with persistent atrial fibrillation and heart failure a retrospective study |
| url | http://dx.doi.org/10.1155/2022/3002391 |
| work_keys_str_mv | AT chengmingma optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy AT yejianhe optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy AT wenwenli optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy AT huamintang optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy AT shiyudai optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy AT xiaomengyin optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy AT xianjiexiao optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy AT yunlongxia optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy AT lianjungao optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy AT yuanjunsun optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy AT zhongzhenwang optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy AT rongfengzhang optimalcatheterablationstrategyforpatientswithpersistentatrialfibrillationandheartfailurearetrospectivestudy |